1,565
Participants
Start Date
June 30, 2004
Primary Completion Date
July 31, 2008
Study Completion Date
September 30, 2008
C31G
The subject will insert one applicator of C31G prior to each episode of vaginal intercourse during her participation in the study.
nonoxynol-9 (N-9)
The subject will insert one applicator of Conceptrol® vaginal gel (nonoxynol-9) prior to each episode of vaginal intercourse during her participation in the study.
New York University, New York
Columbia University, New York
University of Pittsburgh, Pittsburgh
University of Pennsylvania Medical Center, Philadelphia
Johns Hopkins Bayview Medical Center, Baltimore
Jones Institute of Reproductive Medicine, EVMS, Norfolk
The Ohio State University College of Medicine, Columbus
University Hospitals of Cleveland MacDonald Women's Hospital, Cleveland
University of Cincinnati, Cincinnati
U.T. Southwestern Medical Center, Dallas
University of Colorado - Advanced reproductive Medicine, Aurora
California Family Health Council, Los Angeles
California Family Health Council, Berkeley
Oregon Health & Science University, Portland
Bay State Medical Center, Springfield
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Premier Research
OTHER